Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Pharmaceutical Sciences » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Theory of Literature
$270.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Sunitinib: Mechanisms, Interactions and Side Effects
Tell A Friend
 
Tell someone you know about this product.
Sunitinib: Mechanisms, Interactions and Side Effects
Retail Price: $82.00
10% Online Discount
You Pay:

$73.80
Editors: Vasso Anastasia
Book Description:
Tyrosine kinase inhibitors are used to treat patients with advanced thyroid cancers. Sunitinib (SU11248) is an oral small-molecule, oxindol derivative, multi-targeted tyrosine kinase inhibitor that inhibits receptors for platelet-derived growth factor and vascular endothelial growth factor receptors, growth factor receptor, fms-related tyrosine kinase 3, RET oncogene and a multitargeted tyrosine-kinases. In Sunitinib: Mechanisms, Interactions and Side Effects, the authors report nine open-label studies carried out with sunitinb wherein the drug showed its anti-tumoral activity in advanced differentiated thyroid carcinoma, advanced tumors refractory to radioiodine and in medullary thyroid carcinoma, in phase II trials and in retrospective studies.
The aim of the following chapter is to summarize the published results of clinical research focused on the use of sunitinib in pediatric oncology and to supplement it with the experience from the authors’ clinical practice. Suggestions appearing in case reports and clinical trials indicate that sunitinib may be a valuable drug also in pediatric clinical oncology. More attention should be paid to the selection of the most suitable indications, patients, and doses to balance the efficacy and safety in children with malignant diseases.
The concluding review offers a comprehensive overview of phases I and II studies investigating clinical efficacy, tolerability and safety of sunitinib for the treatment of ovarian cancer (OC). Sunitinib was tested in OC due to increasing incidences of resistance to chemotherapy in diseases which have a poor prognosis. Further trials are required to better understand the efficacy of this drug. Regarding its safety-profile, hematologic and non-hematological adverse events are common, but generally not clinically significant. (Nova Medicine and Health)

Table of Contents:
Preface

Chapter 1. Sunitinib in Advanced Differentiated Thyroid Carcinoma
(José-Manuel Gómez-Sáez, Researcher of CIBERDEM (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas), Endocrinology Department, University Hospital of Bellvitge, L´Hospitalet de Llobregat, Barcelona, Spain)

Chapter 2. Sunitinib in the Pediatric Clinical Practice
(Jana Merhautova, Lenka Souckova, Katerina Nebeska, Jaroslav Sterba and Regina Demlova, Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic, and others)

Chapter 3. Sunitinib in Ovarian Cancer: Efficacy and Adverse Effects
(Chiara Bondi, MD, Stefano Di Domenico, MD, Fabio Barra, MD, Valerio Gaetano Vellone, MD, PhD, Franco De Cian, MD and Simone Ferrero, MD, PhD, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Italy, and others)

Index

   Series:
      Pharmacology - Research, Safety Testing and Regulation
   Binding: Softcover
   Pub. Date: 2018 - October
   ISBN: 978-1-53614-239-6
   Status: AN
  
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
  
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Sunitinib: Mechanisms, Interactions and Side Effects